503058-51-3 Usage
Description
4-Chloro-2-chloroMethyl-3-Methoxypyridine, HCl is an organic compound with the molecular formula C10H9Cl2NO2 and a molecular weight of approximately 256.5 g/mol. It is characterized by the presence of a pyridine ring with a methoxy group at the 3rd position, a chloromethyl group at the 2nd position, and a chlorine atom at the 4th position. The hydrochloride salt form of this compound is used in various chemical reactions and pharmaceutical applications.
Uses
Used in Pharmaceutical Industry:
4-Chloro-2-chloroMethyl-3-Methoxypyridine, HCl is used as a reactant for the preparation of symmetric bis-benzimidazole derivatives, which are known for their ability to inhibit gastric acid secretion. This application is particularly relevant in the development of medications for treating conditions related to excessive stomach acid, such as gastroesophageal reflux disease (GERD) and peptic ulcers.
4-Chloro-2-chloroMethyl-3-Methoxypyridine, HCl's unique structure allows it to be a versatile building block in the synthesis of various pharmaceutical agents, potentially leading to the discovery of new drugs with improved efficacy and reduced side effects. Its use in the pharmaceutical industry highlights the importance of organic chemistry in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 503058-51-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,3,0,5 and 8 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 503058-51:
(8*5)+(7*0)+(6*3)+(5*0)+(4*5)+(3*8)+(2*5)+(1*1)=113
113 % 10 = 3
So 503058-51-3 is a valid CAS Registry Number.
503058-51-3Relevant articles and documents
ISOTOPICALLY SUBSTITUTED PROTON PUMP INHIBITORS
-
Page/Page column 15 - 16, (2008/06/13)
The invention relates to benzimidazoles of Formula (1) and to pharmaceutical compositions comprising these compounds, further to intermediates of Formula (2 and 3).
Benzimidazole derivatives
-
Page 4, (2008/06/13)
A benzimidazole derivative of formula (1): (wherein R represents a hydrogen atom or a methoxy group, and n is 0 or 1) or a salt thereof; and a medicament containing the same. The compounds of the present invention, due to minimized difference in therapeutic effect between subjects, which difference would otherwise be derived from different CYP2C19 activity from subject to subject, ensure that all patients can enjoy proper therapeutic effects at the same dose of the drug. Also, the compounds of the invention have low risk of drug interaction caused by induction of CYP1A family member enzymes, as well as low risk of development of cancer, and thus is useful as a remedy for peptic ulcer, reliably providing therapeutic effects with safety.
